analyst
MT
NASDAQ · MTVA
MetaVia Inc.
Healthcare · Biotechnology
$1.46
Up+$0.02 (+1.39%)
Updated Aug 22, 2026, 10:20 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 19.06M
- P/E ratio
- -1.19
- Dividend yield
- 0.00%
- 52-week range
- $0.97 – $4.31
- Volume
- 42.61K
- Avg. volume
- 316.98K
Price performance
MTVA price history
1M range · 21 trading sessions · Daily adjusted prices
MTVA closed at $1.46 after 21 trading sessions, down 1.35% for the selected period.
- Last close
- $1.46
- Period change
- -1.35%
- Period low
- $1.42
- Period high
- $1.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $1.45 | $1.495 | $1.45 | $1.46 | 42.61K |
| Aug 20, 2026 | $1.47 | $1.47 | $1.43 | $1.44 | 42.17K |
| Aug 19, 2026 | $1.46 | $1.50 | $1.4424 | $1.47 | 86.32K |
| Aug 18, 2026 | $1.48 | $1.53 | $1.4353 | $1.49 | 74.87K |
| Aug 17, 2026 | $1.50 | $1.535 | $1.46 | $1.48 | 59.06K |
| Aug 14, 2026 | $1.47 | $1.52 | $1.4636 | $1.49 | 69.21K |
| Aug 13, 2026 | $1.47 | $1.481 | $1.43 | $1.46 | 141.73K |
| Aug 12, 2026 | $1.45 | $1.52 | $1.42 | $1.47 | 211.79K |
| Aug 11, 2026 | $1.45 | $1.47 | $1.42 | $1.42 | 51.61K |
| Aug 10, 2026 | $1.44 | $1.50 | $1.43 | $1.43 | 76.77K |
| Aug 7, 2026 | $1.43 | $1.54 | $1.43 | $1.49 | 108.08K |
| Aug 6, 2026 | $1.4894 | $1.505 | $1.45 | $1.45 | 37.44K |
| Aug 5, 2026 | $1.48 | $1.51 | $1.44 | $1.49 | 46.95K |
| Aug 4, 2026 | $1.48 | $1.53 | $1.46 | $1.46 | 64.23K |
| Aug 3, 2026 | $1.48 | $1.56 | $1.4507 | $1.48 | 35.36K |
| Jul 31, 2026 | $1.41 | $1.46 | $1.38 | $1.42 | 133.2K |
| Jul 30, 2026 | $1.47 | $1.47 | $1.41 | $1.44 | 56.98K |
| Jul 29, 2026 | $1.4231 | $1.49 | $1.41 | $1.44 | 54.81K |
| Jul 28, 2026 | $1.45 | $1.455 | $1.3901 | $1.43 | 55.02K |
| Jul 27, 2026 | $1.49 | $1.52 | $1.42 | $1.45 | 96.52K |
| Jul 24, 2026 | $1.47 | $1.5391 | $1.46 | $1.48 | 71.19K |
Latest MTVA news
The latest Smart Investors Daily articles mentioning MTVA.
Stock researchResearch & News · SEC Filings
Loading stock research…